| Mrs Kimberly M Krasowski, LMHC | |
|
31 Church Ln, Chester, NH 03036-8118 | |
| (603) 858-5240 | |
| Not Available |
| Full Name | Mrs Kimberly M Krasowski |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 31 Church Ln, Chester, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124605480 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 484 (New Hampshire) | Primary |
| Entity Name | The Counseling Center Of Nashua Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144275389 PECOS PAC ID: 3274523758 Enrollment ID: O20040929000288 |
News Archive
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT⢠in patients with non-squamous non-small cell lung cancer (NSCLC).
A more precise method for determining bone marrow involvement in patients with diffuse large B-cell lymphoma-a key factor in tailoring patient management plans-has been identified by researchers in a study published in the August issue of The Journal of Nuclear Medicine.
In 2015, the International Agency for Research on Cancer (IARC) published a series of monographs on the evaluation of various carcinogenic risks. In a monograph on air pollution, the organization pointed out the difficulty of assessing the effects of pollution on multiple types of cancers, given their different etiologies, risk factors and variability in the composition of air pollutants in space and time. However, the IARC identified certain key components of air pollution, including particulates.
A multidisciplinary international team of scientists solved the mystery of a recently discovered type of controlled cell death, mapping the path to potential therapies for conditions ranging from radiation injury to cancer.
Kinetic Muscles Inc., a leading developer of stroke therapy technology, today announced a strategic distribution agreement with Mobility Research, also of Tempe, that will allow Mobility to market KMI's products in specific international markets.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kimberly M Krasowski, LMHC 31 Church Ln, Chester, NH 03036-8118 Ph: (603) 858-5240 | Mrs Kimberly M Krasowski, LMHC 31 Church Ln, Chester, NH 03036-8118 Ph: (603) 858-5240 |
News Archive
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT⢠in patients with non-squamous non-small cell lung cancer (NSCLC).
A more precise method for determining bone marrow involvement in patients with diffuse large B-cell lymphoma-a key factor in tailoring patient management plans-has been identified by researchers in a study published in the August issue of The Journal of Nuclear Medicine.
In 2015, the International Agency for Research on Cancer (IARC) published a series of monographs on the evaluation of various carcinogenic risks. In a monograph on air pollution, the organization pointed out the difficulty of assessing the effects of pollution on multiple types of cancers, given their different etiologies, risk factors and variability in the composition of air pollutants in space and time. However, the IARC identified certain key components of air pollution, including particulates.
A multidisciplinary international team of scientists solved the mystery of a recently discovered type of controlled cell death, mapping the path to potential therapies for conditions ranging from radiation injury to cancer.
Kinetic Muscles Inc., a leading developer of stroke therapy technology, today announced a strategic distribution agreement with Mobility Research, also of Tempe, that will allow Mobility to market KMI's products in specific international markets.
› Verified 1 days ago
Ronald Cummings, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 234 Candia Rd, Chester, NH 03036 Phone: 603-498-4761 |